Literature DB >> 17151470

Refolding and activation of human prorenin expressed in Escherichia coli: application of recombinant human renin for inhibitor screening.

Saori Takahashi1, Hironobu Ogasawara, Takayuki Watanabe, Masanori Kumagai, Hiroyasu Inoue, Kazuyuki Hori.   

Abstract

Human prorenin was expressed in Escherichia coli as a fusion protein of thioredoxin. The chimeric protein, which accumulated insoluble inclusion bodies, was solubilized in 4 M guanidine-HCl and refolded by an arginine-detergent buffer system and by systematic dialysis. The refolded fusion prorenin was activated by trypsin. The antiserum against human kidney renin specifically inhibited the recombinant human renin activity. Using the recombinant human renin, we screened its inhibitory activity in fermented soybean paste (miso) and demonstrated that miso contained renin inhibitory activity derived from soybean. The IC(50) values for soybean and steamed soybean extracts were determined to be 1.9 and 1.6 mg/ml, respectively. This is the first demonstration of renin inhibitory activity in miso and soybean.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151470     DOI: 10.1271/bbb.60334

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

Review 1.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

2.  Purification and characterization of recombinant human renin for X-ray crystallization studies.

Authors:  Zhongren Wu; Maria G Cappiello; Boyd B Scott; Yuri Bukhtiyarov; Gerard M McGeehan
Journal:  BMC Biochem       Date:  2008-06-26       Impact factor: 4.059

3.  L-arginine suppresses aggregation of recombinant growth hormones in refolding process from E. coli inclusion bodies.

Authors:  Egle Bajorunaite; Jolanta Sereikaite; Vladas-Algirdas Bumelis
Journal:  Protein J       Date:  2007-12       Impact factor: 4.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.